Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
1,200.20
-22.30 (-1.82%)
Jan 29, 2026, 1:40 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 1.02 trillion as of January 28, 2026. Its market cap has decreased by -9.42% in one year.
Market Cap
1.02T
Enterprise Value
1.01T
Revenue
345.83B
Ranking
n/a
PE Ratio
18.01
Stock Price
1,200.20
Market Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 1.02T, an increase of 4,752.86%. That is a compound annual growth rate of 15.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 1.03T | -2.44% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.61T |
| Cipla | 1.07T |
| Zydus Lifesciences | 902.49B |
| Mankind Pharma | 864.50B |
| Alkem Laboratories | 687.98B |
| Aurobindo Pharma | 662.06B |
| Glenmark Pharmaceuticals | 564.32B |
| Laurus Labs | 539.96B |